|Day Low/High||66.58 / 67.74|
|52 Wk Low/High||56.56 / 85.97|
I'm setting up a risk reversal to either buy the stock lower or participate in the upside.
Buying's good for the acquirers, which should give other companies ideas.
Prospects for acquisition activity in the sector are improving.
That would mean that there is the chance for a comeback here of some note.
Monday's action failed to change the overall character of the market
"Yeah, well, that's just, like, your opinion, man." -- The Dude, The Big Lebowski Strikes and gutters today -- in a market characterized by winners and losers and weakening breadth. Ups and downs. Amazon's shares may be signaling there is no fun,...
This market is focused on Apple and Gilead's planned acquisition of Kite.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Monday's trending stocks
For the life of me I don't see why Gilead Sciences' shares should respond very positively to the $13 billion acquisition of Kite Pharmaceutical . On Fast Money it is being argued that the takeover is anti-dilutive against cash. So what? It signals ...
The key to dealing with this environment is to keep an open mind.
Multiples have become quite rich and dysfunction in Washington could end up biting the markets.
Markets continue to trade in a very narrow range this Friday, commentary on the Daily Diary is certainly more active than equities today! Most major indices remain slightly down as they have been pretty much since the opening bell. The Dow has just ...
Coming up on the two-hour mark on trading. The market is down slightly down across the board, with Nasdaq being affected by disappointing results from Starbucks and Amazon . The failure to even getting a "skinny" repeal and replacement of the Afford...
It is good to be sitting in for Doug Kass here on the Daily Diary as we look to end the trading week on a positive note. It is also good to see the Yankees start to win close games again after losing so many of them in the weeks leading into the All...
Ford Motor Co. leads a list of notable earnings reports being released throughout the day on Wednesday
But this needs to heat up again for the sector to rally in a big way.
However, it will take acquisition activity to heat up again for the sector to rally in a big way.
The pros hate these three big names, but there's reason to believe they got one wrong.
There are reasons to believe rallies in BioDelivery Sciences and Flexion Therapeutics should continue.
"For a day where the S&P was essentially flat, there was a lot going on beneath the surface. Just a few days ago, everyone was so excited about the rally, but I pointed out that the cumulative advance/decline line (breadth) had not made a higher hig...
Banks, tech and healthcare are all seeing renewed buying.